治疗严重抑郁症的psilocybin:一个更新的系统审查和随机临床试验的元分析
Sepehr Aghajanian1,2, Arman Shafiee1,2, Samira Parvizi Omran3
1Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.
Journal of psychopharmacology (Oxford, England)
|October 31, 2024
概括
西在减少抑郁症症状方面表现出显著的有效性,优于传统疗法. 这一发现支持西作为抑郁症的有前途治疗方法,需要进一步研究.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 目前的抗抑郁药具有有限的治疗效益.
- 研究正在探索新的治疗方法,如抑郁症的迷幻药.
- 一种迷幻化合物psilocybin在缓解抑郁症症状方面表现出潜在的潜力.
研究的目的:
- 系统地审查和对西治疗抑郁症的疗效进行元分析.
- 为了评估psilocybin对抑郁症症状的治疗影响.
主要方法:
- 在Medline和Cochrane图书馆进行了全面的文献搜索.
- 包括研究探讨西对抑郁症的影响的研究.
- 使用混合效应多层模型进行效应大小估计.
- 二次分析评估了随时间推移的有效性.
主要成果:
- 与支持性治疗相结合的西宾的使用,与基线相比,导致抑郁症状显著减少.
- 与安慰剂 (p=0.032) 相比,观察到抑郁症的显著下降.
- 在施用后的不同时间间隔中,psilocybin的积极影响仍然显著.
结论:
- 与单独的心理治疗相比,psilocybin在治疗抑郁症方面表现出更高的疗效.
- 这些发现凸显了psilocybin作为一种强大的治疗抑郁症的药物.
- 建议使用更大的样本大小和更长的随访期进行进一步的研究.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
196
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
196
Depression: Overview
221
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
221
Depressive Disorders: MDD and Dysthymia
61
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
61
Diagnostic and Statistical Manual of Mental Disorders (DSM)
45
The Diagnostic and Statistical Manual of Mental Disorders (DSM) serves as the primary classification system for mental health disorders, providing standardized diagnostic criteria for clinicians and researchers. First published by the American Psychiatric Association (APA) in 1952, the DSM has undergone several revisions to reflect evolving psychiatric understanding. The fifth edition, DSM-5, released in 2013, introduced key updates that expanded diagnostic categories and modified diagnostic...
45
Antidepressant Drugs: Overview
367
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
367
Electroconvulsive Therapy
25
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
25


